These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24103348)

  • 81. Fukushima Daiichi Nuclear Plant accident: Atmospheric and oceanic impacts over the five years.
    Hirose K
    J Environ Radioact; 2016 Jun; 157():113-30. PubMed ID: 27032342
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Natural variation of ambient dose rate in the air of Izu-Oshima Island after the Fukushima Daiichi Nuclear Power Plant accident.
    Maedera F; Inoue K; Sugino M; Sano R; Furue M; Shimizu H; Tsuruoka H; Le Van T; Fukushi M
    Radiat Prot Dosimetry; 2016 Mar; 168(4):561-5. PubMed ID: 26246583
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An overview of current knowledge concerning the health and environmental consequences of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident.
    Aliyu AS; Evangeliou N; Mousseau TA; Wu J; Ramli AT
    Environ Int; 2015 Dec; 85():213-28. PubMed ID: 26425805
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Absence of internal radiation contamination by radioactive cesium among children affected by the Fukushima Daiichi nuclear power plant disaster.
    Tsubokura M; Kato S; Nomura S; Morita T; Sugimoto A; Gilmour S; Kami M; Oikawa T; Kanazawa Y
    Health Phys; 2015 Jan; 108(1):39-43. PubMed ID: 25437518
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Radioiodine in the atmosphere after the Fukushima Dai-ichi nuclear accident.
    Lebel LS; Dickson RS; Glowa GA
    J Environ Radioact; 2016 Jan; 151 Pt 1():82-93. PubMed ID: 26440698
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Whole body counter assessment of internal radiocontamination in patients with end-stage renal disease living in areas affected by the Fukushima Daiichi nuclear power plant disaster: a retrospective observational study.
    Shimmura H; Tsubokura M; Kato S; Akiyama J; Nomura S; Mori J; Tanimoto T; Abe K; Sakai S; Kawaguchi H; Tokiwa M
    BMJ Open; 2015 Dec; 5(12):e009745. PubMed ID: 26644125
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparative analysis of the countermeasures taken to mitigate exposure of the public to radioiodine following the Chernobyl and Fukushima accidents: lessons from both accidents.
    Uyba V; Samoylov A; Shinkarev S
    J Radiat Res; 2018 Apr; 59(suppl_2):ii40-ii47. PubMed ID: 29415268
    [TBL] [Abstract][Full Text] [Related]  

  • 88. (135)Cs/(137)Cs isotopic ratio as a new tracer of radiocesium released from the Fukushima nuclear accident.
    Zheng J; Tagami K; Bu W; Uchida S; Watanabe Y; Kubota Y; Fuma S; Ihara S
    Environ Sci Technol; 2014 May; 48(10):5433-8. PubMed ID: 24779957
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact on ambient dose rate in metropolitan Tokyo from the Fukushima Daiichi Nuclear Power Plant accident.
    Inoue K; Tsuruoka H; Van Le T; Arai M; Saito K; Fukushi M
    J Environ Radioact; 2016 Jul; 158-159():1-8. PubMed ID: 27055250
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Aerosol residence times and changes in radioiodine-131I and radiocaesium-137 Cs activity over Central Poland after the Fukushima-Daiichi Nuclear reactor accident.
    Długosz-Lisiecka M; Bem H
    J Environ Monit; 2012 May; 14(5):1483-9. PubMed ID: 22481111
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pre- and post-accident (129)I and (137)Cs levels, and (129)I/(137)Cs ratios in soil near the Fukushima Dai-ichi Nuclear Power Plant, Japan.
    Matsunaka T; Sasa K; Sueki K; Takahashi T; Satou Y; Matsumura M; Kinoshita N; Kitagawa JI; Matsuzaki H
    J Environ Radioact; 2016 Jan; 151 Pt 1():209-217. PubMed ID: 26492397
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of childhood thyroid cancer prevalence among 3 areas based on external radiation dose after the Fukushima Daiichi nuclear power plant accident: The Fukushima health management survey.
    Ohira T; Takahashi H; Yasumura S; Ohtsuru A; Midorikawa S; Suzuki S; Fukushima T; Shimura H; Ishikawa T; Sakai A; Yamashita S; Tanigawa K; Ohto H; Abe M; Suzuki S;
    Medicine (Baltimore); 2016 Aug; 95(35):e4472. PubMed ID: 27583855
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparison of thyroid doses to the public from radioiodine following the Chernobyl and Fukushima accidents.
    Shinkarev SM
    Ann ICRP; 2021 Jul; 50(1_suppl):174-180. PubMed ID: 34109835
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Radioiodine and radiocesium in Thessaloniki, Northern Greece due to the Fukushima nuclear accident.
    Manolopoulou M; Vagena E; Stoulos S; Ioannidou A; Papastefanou C
    J Environ Radioact; 2011 Aug; 102(8):796-7. PubMed ID: 21549460
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Particle size distribution of radioactive aerosols after the Fukushima and the Chernobyl accidents.
    Malá H; Rulík P; Bečková V; Mihalík J; Slezáková M
    J Environ Radioact; 2013 Dec; 126():92-8. PubMed ID: 23974074
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [A Survey about the Radiation Effects and A Health Survey of Fukushima Inhabitants after the Fukushima Daiichi Nuclear Power Plant Accident].
    Okazaki R; Ohga K; Yoko-O M; Kohzaki M
    J UOEH; 2017; 39(4):277-290. PubMed ID: 29249741
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident.
    Yamashita S; Suzuki S; Suzuki S; Shimura H; Saenko V
    Thyroid; 2018 Jan; 28(1):11-22. PubMed ID: 28954584
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Using animal thyroids as ultra-sensitive biomonitors for environmental radioiodine.
    Steinhauser G; Merz S; Kübber-Heiss A; Katzlberger C
    Environ Sci Technol; 2012 Dec; 46(23):12890-4. PubMed ID: 23098172
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Detection of 131I in a patient with thyroid cancer by internal radiation exposure screening using a whole-body counter in Fukushima.
    Tsubokura M; Nomura S; Ishii T; Kami M; Kato S
    Clin Nucl Med; 2014 Mar; 39(3):281-2. PubMed ID: 24395016
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The time variation of dose rate artificially increased by the Fukushima nuclear crisis.
    Hosoda M; Tokonami S; Sorimachi A; Monzen S; Osanai M; Yamada M; Kashiwakura I; Akiba S
    Sci Rep; 2011; 1():87. PubMed ID: 22355606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.